RxDoctor Payments Data

Clifford Iriele, MD

Psychiatry · Los Angeles, CANPI 1518124718

Payments from drug & device makers

$1,040in general payments, 2019–2025

Across 49 payments — averaging $21.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$401
  • Johnson & Johnson$329
  • Alkermes, Inc.$109
  • Luye Pharma (USA) Ltd.$82
  • Otsuka America Pharmaceutical, Inc.$36
  • Neurocrine Biosciences, Inc.$30
  • plus $52 from 2 others

What the payments were for

  • Food & beverage$1,040100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,040 in reported general payments places this provider in the 75th percentile of 4,954 psychiatry providers in California.

See all psychiatry providers in California

Medicare billing

Part B allowed, 2024
$209,038
Medicare patients
128
Services billed
2,385

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate15$52,210
Clozapine24$4,786
Ziprasidone Hcl25$1,540
Risperidone30$721
Aripiprazole16$625
Duloxetine Hcl21$567
Venlafaxine Hcl ErVenlafaxine Hcl14$557
Lurasidone Hcl12$464
Olanzapine29$429
Quetiapine Fumarate21$359
Divalproex Sodium20$322
Gabapentin30$251
Benztropine Mesylate22$240
Lithium Carbonate26$238
Hydroxyzine Hcl21$182

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$329$52,21015 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 4,954 psychiatry providers in California.

Other psychiatry in Los Angeles

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →